Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777

NCT07003425 is registered in ClinicalTrials.gov with Apogee Therapeutics, Inc. as lead sponsor.

NCT NCT07003425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07003425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777
Lead sponsor
Apogee Therapeutics, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
May 14, 2025
Completion date
December 31, 2029
Enrollment
350 (estimated)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis